Akoya Reports Record Revenue in the Fourth Quarter of 2022 and Provides Full Year 2023 Revenue Guidance
06. März 2023 16:05 ET
|
Akoya Biosciences, Inc.
Q4 2022 revenue $21.2 million and FY 2022 revenue $74.9 millionFY 2023 revenue guidance range $95-98 million MARLBOROUGH, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc....
Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel
28. Februar 2023 08:00 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Jennifer Kamocsay as General...
Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences
06. Februar 2023 08:05 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...
Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting
01. Februar 2023 08:00 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that the company will present results from a...
Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022
08. Januar 2023 16:00 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced preliminary unaudited revenue for the fourth...
Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference
28. Dezember 2022 16:00 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in the 41st Annual...
Akoya Biosciences Showcases Latest Spatial Biology Innovations at Virtual Spatial Day
15. Dezember 2022 16:00 ET
|
Akoya Biosciences, Inc.
New products and partnerships further accelerate and simplify identification of actionable spatial signatures, creating unprecedented opportunities to improve patient outcomes Ready-to-use panels,...
Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy
07. November 2022 16:05 ET
|
Akoya Biosciences, Inc.
Each panel focuses on distinct areas of tumor biology and response to therapy which are of greatest interest to translational and clinical researchers Simplifies biomarker assay development and...
Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance
07. November 2022 16:05 ET
|
Akoya Biosciences, Inc.
Q3 2022 revenue $18.9 million, 40% y/y growthRaising FY 2022 revenue guidance range to $73-75 million MARLBOROUGH, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA)...
Akoya to Participate at Three Upcoming Investor Conferences
03. November 2022 08:05 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in three upcoming...